ABSTRACT. The oxidation of [U-14C]succinic semialdehyde to 14C02 has been investigated in cultured lymphoblasts to develop a whole cell assay for succinic semialdehyde dehydrogenase. We have previously demonstrated deficiency of this enzyme in extracts of white cells derived from 13 patients with 4-hydroxybutyric aciduria. Major goals were the demonstration of greater residual succinic semialdehyde dehydrogenase activity in patient cell lines and the better representation of physiology in vivo. In 18 control lymphoblast lines, the conversion of [U-14~succinic semialdehyde to 14C02 was 1579 f 310 dpm. The mean value in lymphoblasts derived from 11 patients with deficiency of succinic semialdehyde dehydrogenase was 112 f 36 dpm approximating 7% of the mean control value. Analysis of organic acids produced from [U-14qsuccinic semialdehyde in control lymphoblasts indicated that 14C02 emanated from the tricarboxylic acid cycle; the major metabolic products were succinic and lactic acids. In the presence of 5mM malonic and 2-propylpentanoic (valproic) acids, I4CO2 production in a control lymphoblast line was decreased by 68 and 45%, respectively. The whole cell assay is less laborious than our previously described assay employing cell extracts, and the general trend was the demonstration of higher residual levels of activity for lymphoblasts derived from patients. (Pediatr Res 24: 455-460, 1988) 
4-Hydroxybutyric aciduria is a rare inborn error in the metabolism of the neurotransmitter GABA (Fig. 1 ). This disease is unique in that it constitutes metabolic derangement in which a neuropharmacologically active compound accumulates in patient body fluids (1). The underlying defect is a deficiency of SSADH (E.C. 1.2.1.24, Fig. 1 ). Under normal conditions, GABA enters the tricarboxylic acid cycle as succinic acid after transamination and oxidation catalyzed by 4-aminobutyric acid aminotransferase (E.C.2.6.1. 19 ) and SSADH, respectively, In patients, SSA accumulates and is reduced to GHB by 4-hydroxybutyric acid dehydrogenase (E.C. 1.1.1.6 1). The neuropharmacologic actions of GHB have been studied in detail (2) .
In 13 documented patients with 4-hydroxybutyric aciduria the clinical picture was of mild to marked psychomotor retardation, muscular hypotonia, and nonprogressive ataxia. The urinary organic acid profile includes elevated concentrations of GHB, 3,4-dihydroxybutyric acid, and glycolic acid. There may be considerable clinical heterogeneity. Two patients did not display ataxia or convulsions (3, 4) . Three patients, two of whom were siblings, manifested urinary glycinuria (3, 5) . In one patient the urinary organic acid profile was that of 4-hydroxybutyric aciduria and also glutaric aciduria type I1 (Goodman SI, personal communication). Deficient activity of SSADH has been demonstrated in extracts of lymphocytes isolated from whole blood and/or cultured lymphoblasts transformed with EBV in each of the 13 patients (6) .
We have investigated the oxidation of [U-'4C]SSA to I4CO2 in intact EBV-transformed cultured human lymphoblasts in 1 1 patients with 4-hydroxybutyric aciduria. The objective of the study was the development of a whole cell assay in which greater residual activity might better represent physiology in vivo and distinguish variants with differing phenotypes. Lymphocytes isolated from whole venous blood (8) were transformed with EBV according to the procedure of Sly et al. (9) .
During the initial phase of transformation, lymphocytes were maintained in RPMI 1640 medium supplemented with 20% fetal bovine serum, penicillin, streptomycin, fungizone and glutamine. For maintenance of transformants, the culture medium was identical except that fungizone was omitted and the concentration of bovine serum was decreased to 10%. All cell lines were screened for mycoplasma contamination. Lymphoid lines were prepared from 18 control individuals, eleven patients with deficiency of SSADH and seven family members (six parents and a clinically unaffected male sibling).
The oxidation of [U-14C]SSA (0.02 jCi/assay) was assessed in 15 ml plastic conical centrifuge tubes fitted with septa and center wells. Lymphoblasts in the log-phase of growth were harvested by centrifugation for 10 min at 800 x g. The cells were washed twice with PBS and reisolated. After the final wash, cells were resuspended in a total volume of 0.3 ml of PBS supplemented with 0.1 % glucose and 0.4 mg/ml defatted bovine serum albumin (10) at a final concentration of 2 x lo6 cells/0.3 ml. Tubes were incubated for 90 minutes in a shaking water bath at 37" C. Reactions were stopped by addition of 0.1 ml 4.2 M HC104 through septa with a Hamilton syringe, after which 0.1 ml of 3 N KOH was added to the center well for I4CO2 collection. Trapping of I4CO2 was camed out for 1 h on ice. The contents of center wells were transferred to 22 ml glass scintillation vials containing 10 ml of EcoLite scintillation fluid (West Chem, San Diego, CA). Wells were rinsed with 0.15 ml deionized water that was also added to vials. The vials were counted in a Beckman LS 3801 liquid scintillation spectrophotometer after storage for 24 h in the dark to facilitate decay of chemiluminescence.
The oxidation of [U-14C]SSA in each cell line was measured in duplicate for two separate harvests of cells; the final I4CO2 dpm values represent the mean of both harvests. For the analysis of organic acids, duplicate acidified reaction mixtures were pooled in 22 ml glass scintillation vials and neutralized with 6 N KOH, the insoluble K C 104 removed by centrifugation, and the supernatant fluids lyophilized to dryness. Each vial received 0.05 ml 28% methoxylamine hydrochloride, 0.03 ml 14% sodium hydroxide and 2.8 microequivalents nonradiolabeled camer SSA (Sigma). In this way unreacted [U-14C]SSA was converted to its methoxime. Radiolabeled organic acids were separated and quantified by liquid partition chromatography as previously described (1 1 eluted at approximately 5 min and did not interfere with the quantification of other I4C-organic acids.
RESULTS
The production of I4CO2 was linear with up to 3 x 10"ontrol cells incubated and with time up to 120 min (Fig. 2) . The mean production of I4CO2 from [U-14C]SSA in 18 control lymphoblast lines was 1579 k 310 dpm (Table 1 ). The mean value of cell lines derived from 1 1 patients with SSADH deficiency was 1 12 + 36 dpm, approximately 7% of the mean control value. In seven family members, the mean I4CO2 production in cultured lymphoblasts was 1428 & 239 dpm approximating the mean control value. Furthermore, the range of values for family members was similar to the control range, and there was no evidence for two populations of family members.
Investigation of the production of I4C-organic acids was undertaken in the presence and absence of different metabolic inhibitors in order to determine the metabolic sources of the I4CO2 produced (Table 2 ). In the control reaction mixture, the major I4C-organic acids were succinic and lactic acids; smaller amounts of I4C were found in fumaric, malic, and citric acids. These data suggested that the I4CO2 production resulted from action of the TCA cycle. The inclusion of 5 mM unlabeled GHB did not result in a decrease in I4CO2 production or in a significant alteration in the pattern of 14C-organic acid production, suggesting that GHB was not involved in the metabolic transformation of [U-14C]SSA in intact lymphoblasts. The inclusion of 5 mM malonic acid caused a 68% decrease in I4CO2 production. Concomitantly, there was an approximately 10-fold increase in isotope in succinic acid, and decreases in the isotope content in fumaric, lactic, and malic acids. These data indicate that [U-I4C] SSA entered the TCA cycle at the level of succinic acid and was consistent with the expected inhibition by malonic acid of succinic dehydrogenase.
The effects of valproic acid were not so clear. I4CO2 production from [U-14C]SSA was decreased by 45%. However, there were increases in the isotope content of all of the organic acids, including an approximate 3-fold increase in malic acid.
The whole cell assay might be expected to yield higher residual SSADH activity in patient lymphoblast lines, and this was the case in each instance (Fig. 3) . The mean oxidation of [U-I4C] SSA to I4CO2 in intact lymphoblasts derived from eleven patients was 7.1 + 2.3% (+ 1 SD) ( Fig. 3; Table 3 ) of the mean control value. In contrast, residual SSADH activity in extracts of lymphoblasts derived from the same 1 1 patients was 1.6% & 1.8% in comparison to simultaneously assayed mean control values. Furthermore, the intact cell assay appeared of value in distinguishing distinct patient populations based on residual SSADH activity (4-5% for sibship a, 7-8% for sibship b, and 9-1 1 % for sibship c) (Fig. 3) .
DISCUSSION
have demonstrated that the use of an intact cell assay permits the distinction of distinct variants with differing amounts of residual activity and good correlations between severity of clinical phenotype and severity of enzymatic deficiency. In contrast, cell free systems seldom permit such correlations because so many variants display essentially zero activity, presumably because mutant enzymes are inherently labile. Moreover, the coefficient of variation of less than 20% for 18 control cell lines was significantly smaller than the same value obtained with cell extract assays and far fewer control cell lines. The simplicity of the assay and the ease of production of [U-14C]SSA from [U-I4C] GABA (7) provide advantages over our previously described assay for SSADH using cell extracts (6) and should facilitate the use of the intact cell oxidation assay in other laboratories.
Activities of SSADH in cell extracts have been previously reported (4, 5, 6, 13-1 5) for eight of 13 patients with 4-hydroxybutyric aciduria. The residual activity of SSADH in 1 1 patients in lymphoblast extracts ranged from 0-6% of control. The mean oxidation of [U-I4C]SSA to 14C02 in intact lymphoblasts derived from these patients was higher at approximately 7% of the control mean (Fig. 3) . Moreover, the intact cell assay appears to be a more reliable method for assessing residual SSADH activity because the coefficient of variation for I4CO2 production in control cell lines was appreciably smaller than found in cell extracts. In fact, in previously reported studies of SSADH activity in extracts of lymphoblasts the coefficients of variation of control SSADH activity were 16, 35, 38, and 49% (4, 13-15). These studies used four to five control lines. In the present study 18 control cell lines were used and the coefficient of variation was less than 20%.
The clinical and enzymatic phenotypes of patients with 4-hydroxybutyric aciduria are displayed in Table 3 . There was little Measurement of the oxidation of [U-14C]SSA to 14C02 in intact cultured lymphoblasts has provided a convenient means of assessing residual activity of SSADH. Deficient activity of SSADH was readily documented in the eleven patients with 4-hydroxybutyric aciduria studied. The use of an intact cell assay appears intuitively to represent a more physiologic assessment of SSADH activity than an assay employing cell extracts. We (12) and others 11 Both siblings noted as having nonspecific muscle atrophy.
n Lymphocyte extracts; all other values in this column were generated using lymphoblast extracts. ** Glasgaw AM, personal communication. * Values in parentheses refer to patient numbers in Table 3 .
I4C-SSA OXIDATION IN HUMAN LYMPHOBLASTS
t During a period of extended studies of SSADH activity in control lymphocytes and lymphoblasts, there was no significant difference between control mean SSADH values for the two cell types.
variation between cell lines in the residual level of SSADH activity when intact cells derived from eleven patients were studied. In contrast, there were two distinct patient populations in terms of enzymatic phenotype when lymphocyte extracts were employed for determination of residual SSADH activities. In lymphocyte extracts derived from patients 1-3 and 7-1 1 SSADH activity ranged from 0-3.8% of parallel controls. Conversely, residual SSADH levels were 5.7, 14.2, and 19.4% of parallel controls in lymphocyte extracts derived from patients 4, 12, and 13. Despite inherent difficulties in grading the clinical presentation of patients with inherited metabolic defects, it would nonetheless appear that the latter three probands represent the least severely affected patients with 4-hydroxybutyric aciduria thus far described, an observation well correlated with the residual SSADH activities displayed in lymphocyte extracts. The intact cell assay is not useful for heterozygote genotyping in family members (Table 4 ). The mean oxidation of [U-I4C] SSA to I4CO2 in lymphoblasts derived from seven family members of patients was 90 f 15% ( f 1 SD) of the mean value in controls. Four of these seven individuals (two sets of parents) are obligate heterozygotes, since two affected offspring have occurred in each family. Conversely, heterozygosity has been readily documented in the assay of cell extracts (Table 4) . For obligate heterozygotes depicted in Table 4 , the mean SSADH in comparison to simultaneously assayed control values was 51 +: 18% (nos. 1-4, 8-1 1, f 1 SD, range 27-79%) for both cell types. The activities of SSADH in extracts of lymphoblasts and lymphocytes derived from four additional parents (family members 5, 6, 14, and 15) ( Table 4) ranged from 30-58% of parallel mean control values, suggesting their status as camers of the mutant gene. For clinically unaffected siblings depicted in Table 4 (family members 7, 12, 13, and 16) the data suggested two as heterozygotes and two as homozygous unaffected.
The generation of I4CO2 from [U-14C]SSA in intact lymphoblasts was interpreted to emanate from the operation of the tricarboxylic acid cycle. Production of I4CO2 was markedly curtailed in the presence of malonic acid, and isotope accumulated in succinic acid. Valproic acid has been reported to inhibit GABA-aminotransferase and SSADH in ox brain (16) and rat brain (17) (18) (19) (20) . We observed an inhibition of I4CO2 production from [U-14C]SSA in intact lymphoblasts in the presence of 5 mM valproic acid. Moreover, in an in vitro assay ( 6 ) using lymphoblast extract as source of enzyme we found that concentrations of 0.5-10 mM valproic acid inhibited SSADH by 39-58%, values similar to the 45% inhibition of I4CO2 production observed in intact cells. However, the content of isotope in succinic and lactic acids was similar to control levels and even higher in fumaric and malic acids. If valproic acid had an inhibitory effect on malic enzyme, one might expect decreased production of I4C-lactic acid, which was not the case.
The intact cultured cell assay is both rapid and simple. It should allow for more reliable assessment of residual enzyme activity in patients and will be of value in distinguishing distinct patient populations within families based on residual SSADH levels. However, the assay of SSADH using cell extracts remains at present the most reliable method of heterozygote detection in family members. For patients and family members yet to be discovered, it will be of value to use both types of assays.
